TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive HHS Drops Misconduct allegations Against NCI’s Gallo Days Before Appeals Hearing November 19, 1993